| Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR VM Corman, O Landt, M Kaiser, R Molenkamp, A Meijer, DKW Chu, ... Eurosurveillance 25 (3), 2000045, 2020 | 3029 | 2020 |
| Re-emergence of fatal human influenza A subtype H5N1 disease JSM Peiris, WC Yu, CW Leung, CY Cheung, WF Ng, JM Nicholls, TK Ng, ... The Lancet 363 (9409), 617-619, 2004 | 1031 | 2004 |
| Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome T Kuiken, RAM Fouchier, M Schutten, GF Rimmelzwaan, ... The Lancet 362 (9380), 263-270, 2003 | 1013 | 2003 |
| Commentary: Middle east respiratory syndrome coronavirus (mers-cov): announcement of the coronavirus study group RJ De Groot, SC Baker, RS Baric, CS Brown, C Drosten, L Enjuanes, ... Journal of virology 87 (14), 7790-7792, 2013 | 1004 | 2013 |
| Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study E Miller, K Hoschler, P Hardelid, E Stanford, N Andrews, M Zambon The Lancet 375 (9720), 1100-1108, 2010 | 823 | 2010 |
| Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction VM Corman, I Eckerle, T Bleicker, A Zaki, O Landt, M Eschbach-Bludau, ... Eurosurveillance 17 (39), 20285, 2012 | 582 | 2012 |
| Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza KG Nicholson, AE Colegate, A Podda, I Stephenson, J Wood, E Ypma, ... The Lancet 357 (9272), 1937-1943, 2001 | 501 | 2001 |
| Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012 A Bermingham, MA Chand, CS Brown, E Aarons, C Tong, C Langrish, ... Eurosurveillance 17 (40), 20290, 2012 | 496 | 2012 |
| Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial JL Bresson, C Perronne, O Launay, C Gerdil, M Saville, J Wood, ... The Lancet 367 (9523), 1657-1664, 2006 | 484 | 2006 |
| Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007–08 season A Meijer, A Lackenby, O Hungnes, B Lina, S van der Werf, B Schweiger, ... Emerging infectious diseases 15 (4), 552, 2009 | 442 | 2009 |
| Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study MC Zambon, JD Stockton, JP Clewley, DM Fleming The Lancet 358 (9291), 1410-1416, 2001 | 427 | 2001 |
| Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use AS Monto, JL McKimm-Breschkin, C Macken, AW Hampson, A Hay, ... Antimicrobial agents and chemotherapy 50 (7), 2395-2402, 2006 | 418 | 2006 |
| Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir J McKimm-Breschkin, T Trivedi, A Hampson, A Hay, A Klimov, M Tashiro, ... Antimicrobial agents and chemotherapy 47 (7), 2264-2272, 2003 | 386 | 2003 |
| Human metapneumovirus as a cause of community-acquired respiratory illness J Stockton, I Stephenson, D Fleming, M Zambon Emerging infectious diseases 8 (9), 897, 2002 | 383 | 2002 |
| Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe A Lackenby, O Hungnes, SG Dudman, A Meijer, WJ Paget, AJ Hay, ... Eurosurveillance 13 (5), 3-4, 2008 | 375 | 2008 |
| Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses J Stockton, JS Ellis, M Saville, JP Clewley, MC Zambon Journal of clinical microbiology 36 (10), 2990-2995, 1998 | 372 | 1998 |
| Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study AC Hayward, EB Fragaszy, A Bermingham, L Wang, A Copas, ... The Lancet Respiratory Medicine 2 (6), 445-454, 2014 | 350 | 2014 |
| Epidemiology and pathogenesis of influenza MC Zambon Journal of Antimicrobial Chemotherapy 44 (suppl_2), 3-9, 1999 | 337 | 1999 |
| Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a … I Stephenson, R Bugarini, KG Nicholson, A Podda, JM Wood, MC Zambon, ... The Journal of infectious diseases 191 (8), 1210-1215, 2005 | 335 | 2005 |
| Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans C De Santo, M Salio, SH Masri, LYH Lee, T Dong, AO Speak, S Porubsky, ... The Journal of clinical investigation 118 (12), 4036-4048, 2008 | 320 | 2008 |
